Analyst Ratings for DUSA Pharmaceuticals (DUSA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/11/2012 | Leerink Partners | N/A | New Coverage | Outperform (N/A) |
8.00 (N/A) |
4.48 (51.03) |
1039.06% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/11/2012 | Leerink Partners | N/A | New Coverage | Outperform (N/A) |
8.00 (N/A) |
4.48 (51.03) |
1039.06% | Details |